137 related articles for article (PubMed ID: 32903213)
1. Evidence that dysplasia related microRNAs in Barrett's esophagus target PD-L1 expression and contribute to the development of esophageal adenocarcinoma.
Xu J; Yin Z; Yang L; Wu F; Fan J; Huang Q; Jin Y; Yang G
Aging (Albany NY); 2020 Sep; 12(17):17062-17078. PubMed ID: 32903213
[TBL] [Abstract][Full Text] [Related]
2. Circulating Serum Exosomal miRNAs As Potential Biomarkers for Esophageal Adenocarcinoma.
Chiam K; Wang T; Watson DI; Mayne GC; Irvine TS; Bright T; Smith L; White IA; Bowen JM; Keefe D; Thompson SK; Jones ME; Hussey DJ
J Gastrointest Surg; 2015 Jul; 19(7):1208-15. PubMed ID: 25943911
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.
Sreedharan L; Mayne GC; Watson DI; Bright T; Lord RV; Ansar A; Wang T; Kist J; Astill DS; Hussey DJ
World J Gastroenterol; 2017 Aug; 23(30):5508-5518. PubMed ID: 28852310
[TBL] [Abstract][Full Text] [Related]
4. Circulating exosomal miRNAs as potential biomarkers for Barrett's esophagus and esophageal adenocarcinoma.
Lv J; Zhao HP; Dai K; Cheng Y; Zhang J; Guo L
World J Gastroenterol; 2020 Jun; 26(22):2889-2901. PubMed ID: 32587437
[TBL] [Abstract][Full Text] [Related]
5. Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.
Slaby O; Srovnal J; Radova L; Gregar J; Juracek J; Luzna P; Svoboda M; Hajduch M; Ehrmann J
Carcinogenesis; 2015 May; 36(5):521-7. PubMed ID: 25784377
[TBL] [Abstract][Full Text] [Related]
6. Profiling of circulating microRNAs in patients with Barrett's esophagus and esophageal adenocarcinoma.
Bus P; Kestens C; Ten Kate FJ; Peters W; Drenth JP; Roodhart JM; Siersema PD; van Baal JW
J Gastroenterol; 2016 Jun; 51(6):560-70. PubMed ID: 26585599
[TBL] [Abstract][Full Text] [Related]
7. Deciphering the unique microRNA signature in human esophageal adenocarcinoma.
Saad R; Chen Z; Zhu S; Jia P; Zhao Z; Washington MK; Belkhiri A; El-Rifai W
PLoS One; 2013; 8(5):e64463. PubMed ID: 23724052
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1.
Streppel MM; Pai S; Campbell NR; Hu C; Yabuuchi S; Canto MI; Wang JS; Montgomery EA; Maitra A
Clin Cancer Res; 2013 Aug; 19(15):4067-78. PubMed ID: 23757351
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma.
Wu X; Ajani JA; Gu J; Chang DW; Tan W; Hildebrandt MA; Huang M; Wang KK; Hawk E
Cancer Prev Res (Phila); 2013 Mar; 6(3):196-205. PubMed ID: 23466817
[TBL] [Abstract][Full Text] [Related]
10. A Systematic Review of Esophageal MicroRNA Markers for Diagnosis and Monitoring of Barrett's Esophagus.
Mallick R; Patnaik SK; Wani S; Bansal A
Dig Dis Sci; 2016 Apr; 61(4):1039-50. PubMed ID: 26572780
[TBL] [Abstract][Full Text] [Related]
11. miR-24-3p regulates CDX2 during intestinalization of cardiac-type epithelium in a human model of Barrett's esophagus.
Gil-Gómez G; Fassan M; Nonell L; Garrido M; Climent M; Anglada R; Iglesias M; Guzzardo V; Borga C; Grande L; de Bolós C; Pera M
Dis Esophagus; 2021 Jul; 34(7):. PubMed ID: 33558874
[TBL] [Abstract][Full Text] [Related]
12. Differential MicroRNA Signatures in the Pathogenesis of Barrett's Esophagus.
Craig MP; Rajakaruna S; Paliy O; Sajjad M; Madhavan S; Reddy N; Zhang J; Bottomley M; Agrawal S; Kadakia MP
Clin Transl Gastroenterol; 2020 Jan; 11(1):e00125. PubMed ID: 31934893
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium.
Drahos J; Schwameis K; Orzolek LD; Hao H; Birner P; Taylor PR; Pfeiffer RM; Schoppmann SF; Cook MB
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):429-37. PubMed ID: 26604271
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma.
Kan T; Meltzer SJ
Curr Opin Pharmacol; 2009 Dec; 9(6):727-32. PubMed ID: 19773200
[TBL] [Abstract][Full Text] [Related]
15. The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis.
Leidner RS; Ravi L; Leahy P; Chen Y; Bednarchik B; Streppel M; Canto M; Wang JS; Maitra A; Willis J; Markowitz SD; Barnholtz-Sloan J; Adams MD; Chak A; Guda K
Genes Chromosomes Cancer; 2012 May; 51(5):473-9. PubMed ID: 22302717
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus.
Maru DM; Singh RR; Hannah C; Albarracin CT; Li YX; Abraham R; Romans AM; Yao H; Luthra MG; Anandasabapathy S; Swisher SG; Hofstetter WL; Rashid A; Luthra R
Am J Pathol; 2009 May; 174(5):1940-8. PubMed ID: 19342367
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of circulating miR130a is correlated with development of Barrett's esophagus and esophageal adenocarcinoma.
Wang L; Ji F; Liu G; Wang W; Li Z; Yue Y; Wang Z
Onco Targets Ther; 2019; 12():1-7. PubMed ID: 30588024
[TBL] [Abstract][Full Text] [Related]
18. Identification of miRNAs and genes for predicting Barrett's esophagus progressing to esophageal adenocarcinoma using miRNA-mRNA integrated analysis.
Yao C; Li Y; Luo L; Xiong Q; Zhong X; Xie F; Feng P
PLoS One; 2021; 16(11):e0260353. PubMed ID: 34818353
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression differentiates squamous epithelium from Barrett's esophagus and esophageal cancer.
Garman KS; Owzar K; Hauser ER; Westfall K; Anderson BR; Souza RF; Diehl AM; Provenzale D; Shaheen NJ
Dig Dis Sci; 2013 Nov; 58(11):3178-88. PubMed ID: 23925817
[TBL] [Abstract][Full Text] [Related]
20. Extracellular miRNAs for the Management of Barrett's Esophagus and Esophageal Adenocarcinoma: A Systematic Review.
Inokuchi K; Ochiya T; Matsuzaki J
J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33396321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
